C030:F:F-Lyxor DJ Switzerland Titans 30 (DR) UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 161.48

Change

-2.26 (-1.38)%

Market Cap

USD 0.01B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-20 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

N/A

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.06 (+0.11%)

USD 108.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 93.32B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.01 (+0.02%)

USD 86.92B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.65 (+0.27%)

USD 53.24B
VUSA:F Vanguard Funds Public Limited ..

+0.97 (+1.01%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.39 (-0.40%)

USD 51.63B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 51.19B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 41.09B
0ZC:F Zscaler Inc

+0.14 (+0.09%)

USD 37.92B

ETFs Containing C030:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.02% 58% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.02% 55% F 55% F
Trailing 12 Months  
Capital Gain 11.32% 53% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.32% 49% F 52% F
Trailing 5 Years  
Capital Gain 46.08% 69% C- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 46.08% 69% C- 56% F
Average Annual (5 Year Horizon)  
Capital Gain 8.03% 68% D+ 66% D+
Dividend Return 8.03% 66% D+ 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.12% 61% D- 85% B
Risk Adjusted Return 72.24% 82% B 86% B+
Market Capitalization 0.01B 4% F 13% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.